📰 Affinity Technologies News
Page 7 - Affinity Technologies News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Affinity Technologies. Real-time updates on events, politics, business and more.
June 9, 2023
Shares of bioAffinity Technologies, Inc. (NASDAQ:BIAF – Get Rating) dropped 0.4% during mid-day trading on Tuesday . The stock traded as low as $1.76 and last traded at $1.85. Approximately 8,357 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 765,556 shares. The stock had previously closed at […]
June 5, 2023
Luna Innovations (NASDAQ:LUNA – Get Rating) and bioAffinity Technologies (NASDAQ:BIAF – Get Rating) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, earnings, valuation, dividends and analyst recommendations. Profitability This table compares Luna Innovations and bioAffinity […]
May 22, 2023
BioAffinity Technologies, Inc. , a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today will present the poster... | May 22, 2023
May 17, 2023
BioAffinity Technologies (NASDAQ:BIAF – Get Rating) and Bioqual (OTCMKTS:BIOQ – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Earnings & Valuation This table compares bioAffinity Technologies and Bioqual’s […]
May 15, 2023
BioAffinity Technologies, Inc. , a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for... | May 15, 2023
May 15, 2023
15.05.2023 - bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three months ended March ...
May 10, 2023
Medpace (NASDAQ:MEDP – Get Rating) and bioAffinity Technologies (NASDAQ:BIAF – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability. Institutional and Insider Ownership 82.5% of Medpace shares are owned by […]
May 5, 2023
BioAffinity Technologies, Inc. (NASDAQ:BIAF – Get Rating)’s stock price was down 1% during mid-day trading on Tuesday . The company traded as low as $2.02 and last traded at $2.03. Approximately 8,182 shares traded hands during trading, a decline of 99% from the average daily volume of 983,699 shares. The stock had previously closed at […]
May 5, 2023
A company's external contributors, like content creators, gig workers, and even app developers, will be considered part of the workforce, according to researchers.
May 1, 2023
BioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer, today announced that Michael Dougherty has joined... | May 1, 2023